Up Next
Back to Show
Amanpour & Co.
Jennifer Doudna on FDA Approval of First CRISPR Treatments
More than a decade ago, pioneering biochemist Jennifer Doudna co-invented CRISPR, the gene editing technology which earned her the Nobel Prize in chemistry. Now, the very first treatment based on CRISPR has been approved in the U.K. and the U.S., a landmark decision for the treatment of sickle cell disease and for the potential of this rapidly advancing field. Dr. Doudna joins to discuss.
Support Provided By
Unlock with PBS Passport
55:27
Russel L. Honoré; Eugene Korolev; Polina Sychova; Ken Burns
Unlock with PBS Passport
55:31
Thant Myint-U; Werner Herzog; Arundhati Roy
Unlock with PBS Passport
55:49
Halla Tomasdottir; Pamela Hogan; Gayle Young; Cory Doctorow
Unlock with PBS Passport
55:43
Chase Strangio; Gilbert & George; Tom Gjelten
Unlock with PBS Passport
55:50
Clare Sebastian; Marietje Schaake; Bess Wohl; Kristolyn Lloyd; Zoe Weissman
Unlock with PBS Passport
55:50
David A. Graham; Brian Winter; Larry Madowo; Steve Huffman
Unlock with PBS Passport
55:51
Kurt Volker; Tymofiy Mylovanov; Yousef Sweid; Isabella Sedlak; Saikrishna Prakash
Unlock with PBS Passport
55:50
Gabi Kaltmann; Alicia Kearns; Park Chan-Wook; Sen. Andy Kim
Unlock with PBS Passport
55:40
Ruti Teitel; Aria Florant; Jonathan Freedland; Kate Shaw
Unlock with PBS Passport
55:50
Stefano Pozzebon; Leopoldo López; Shannon Heffernan; Julieta Martinelli; Susan Glasser
Unlock with PBS Passport
55:50
David Dimbleby; Kiran Desai; Zaynab Mohamed
Unlock with PBS Passport
55:43
Celeste Wallander; Peter Frankopan; Mohammed bin Abdulrahman al-Thani; Kaja Kallas; David Remnick